Antimicrobial resistance summit 2020

Memo

The private sector is a hive of ideas and investment—and when it comes to antimicrobial resistance, it needs to be. Without financial backing and urgent policy attention we will face a public health crisis, but this is not just a human issue. Environment, food, and agriculture are often-overlooked domains of AMR. Join policymakers, pharmaceutical companies, academic researchers and NGOs as we explore the future of artificial intelligence, machine learning and data collection in the fight against AMR. The conference will include country-specific case studies, and link themes and discussions to the twinned Economist Events Antimicrobial Resistance Summit Asia that was held in Singapore this December 2019. The end goal will be to bring together all segments of the AMR ecosystem and identify productive models, innovations and partnerships to advance global efforts in fighting this major threat to public health. Time: 9:00 am - 6:00 pm Prices: Earlybird Rate (ex. VAT) - Expires January 23rd: GBP 695.00,Standard Rate (ex.VAT): GBP 895.00,The Economist Subscriber Rate (ex.VAT): GBP 556.00,Academic/Government/Public Sector/Charity/NGO rate (ex.VAT): GBP 595.00 Speakers: Eveline Wesangula, AMR Focal Point, Ministry of Health, Kenya, Benedetta Allegranz, Department of Service Delivery and Safety, World Health Organisation (WHO), Till Bachmann, Deputy head , infection medicine, University of Edinburgh, Peter Beyer, Senior advisor, public health, innovation and intellectual property, Department of Essential Medicines and Health Products, World Health Organization (WHO), Peter Brocklehurst, Director, Birmingham Clinical Trials Unit, University of Birmingham, Michele Cecchini, Senior Economist, Health Division, OECD, Paul Chapman, Office Managing Partner, Marks and Clerk LLP, Allan Coukell, Senior Director of Health Program, The Pew Charitable Trusts, Jeroen Dewulf, Founder and chair, Centre of Expertise on Antimicrobial Use and Resistance in Animals (AMCRA), Colum Dunne, Centre for Interventions in Infection, Inflammation and Immunity, University of Limerick, Marco Haenssgen, Assistant professor, global sustainable development, University of Warwick, Dick Heederik, Head of the Division of Environmental Epidemiology of IRAS, Utrecht University, Ana Maria De Roda Husman, Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Gwyn Jones, Chairman, Responsible Use of Medicines in Agriculture Alliance (RUMA), Zuzana Kusynová, Lead for policy, practice and compliance, International Pharmaceutical Federation (FIP), Chantal Morel, Infection Control Programme, University of Geneva Hospitals, Kevin Outterson, Executive director, Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X), Rosanna Peeling, Director - International Diagnostics Centre, London School of Hygiene and Tropical Medicine, Koen Pouwels, Senior researcher, Health Economics Research Centre, Oxford University, Andreas Sandgren, Deputy head, ReAct Europe, Luigia Scudeller, Clinical Epidemiologist, Scientific Direction of IRCCS Policlinic San MatteoFoundation, Jean-Claude Sirard, Institut Pasteur de Lille, Centre d'Infection et d'Immunite France, Jorgen Stassijns, AMR Task Force Leader, Medecins Sans Frontieres, Evelina Tacconelli, Tubingen University Hospital, Adrian Towse, Director Emeritus, Office of Health Economics, Jaap Wagenaar, Professor of Clinical Infectiology, Department of Infectious Diseases and Immunology, Utrecht University, Elaine Warburton, Group chief executive officer, QuantuMDx Group Ltd, Fiona Wood, Reader, Division of Population Medicine, Cardiff University, Penny Wilson, Senior Specialist – diagnostics, Innovate UK Venue details: BMA House Conference and Events Venue, Tavistock Square, London, England, WC1H 9JP, United Kingdom